Mechanisms and treatment of metabolic dysfunction-associated fatty liver disease after liver transplantation
World Journal of Gastrointestinal Surgery · 27.08.2026 · 18 (8)
DOI: 10.4240/wjgs.121285 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Surgery, online erschienen am 27.08.2026. Verfasst von Jun-Rong Liu und 4 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
Metabolism dysfunction-associated fatty liver disease (MAFLD) has emerged as a frequent complication for liver transplant (LT) recipients. In view of the high incidence of MAFLD after LT, research on MAFLD is of considerable clinical significance. Key research areas include the mechanisms responsible for the development of MAFLD following LT, therapeutic strategies, and the optimization of immunosuppressive regimens to achieve a balance between graft protection and metabolic protection. Most existing studies relating to MAFLD following LT are clinical observational studies, and the majority of investigations into pharmacological aspects are based on non-transplantation populations, thus highlighting significant gaps in research. In this review, we propose that the development of MAFLD after LT is primarily driven by the use of immunosuppressive agents and comprehensively synthesize the existing evidence regarding pathogenesis, immunosuppressive optimization strategies, and therapeutic approaches. Specifically, we focus on mechanistic analyses centered on insulin resistance pathways to elucidate immunosuppression-related mechanisms underlying the development and progression of MAFLD following LT. Based on the evaluation of current immunosuppressive optimization strategies and therapeutic agents, we propose several important directions for future research: Optimizing immunosuppressive regimens, conducting transplant recipient-specific pharmacological studies, and exploring strategies to balance metabolic protection with graft preservation.
Zitieren
APA
Liu, J., Zhao, L., Niu, Q., Cai, J., & Liu, H. (2026). Mechanisms and treatment of metabolic dysfunction-associated fatty liver disease after liver transplantation. World Journal of Gastrointestinal Surgery, 18(8). https://doi.org/10.4240/wjgs.121285
Vancouver
Liu J, Zhao L, Niu Q, Cai J, Liu H. Mechanisms and treatment of metabolic dysfunction-associated fatty liver disease after liver transplantation. World Journal of Gastrointestinal Surgery. 2026;18(8). doi:10.4240/wjgs.121285
BibTeX
@article{Liu2026,
author = {Liu, Jun-Rong and Zhao, Liu and Niu, Qing-Hui and Cai, Jin-Zhen and Liu, Han-Yun},
title = {Mechanisms and treatment of metabolic dysfunction-associated fatty liver disease after liver transplantation},
journal = {World Journal of Gastrointestinal Surgery},
year = {2026},
volume = {18},
number = {8},
doi = {10.4240/wjgs.121285}
}
EUVIMED